School of Medicine
Showing 5,681-5,700 of 12,921 Results
-
Juliet Klasing Knowles
Assistant Professor of Neurology and Neurological Sciences (Pediatric Neurology) and of Pediatrics
Current Research and Scholarly InterestsThe Knowles lab studies how white matter structure changes in different forms of epilepsy, and how aberrant white matter structure, in turn, shapes neuronal network function. In mouse models, we use a variety of innovative tools including neurophysiology, quantitative EEG, behavior, histological measures of white matter structure and MR imaging. We also conduct clinical research to study white matter abnormalities in children with epilepsy.
-
Lisa Marie Knowlton, MD, MPH, FACS, FRCSC
Associate Professor of Surgery (General Surgery)
BioDr. Knowlton is an Associate Professor of Surgery and an Acute Care Surgeon whose practice encompasses trauma surgery, emergency general surgery and surgical critical care. She is an NIH and ARPA-H funded researcher whose focus is on improving access to innovative, high-quality surgical care. She obtained her medical degree at McGill University and completed her general surgery residency at the University of British Columbia in Vancouver, Canada. Her desire to understand varied healthcare systems and develop policy solutions led her to obtain an M.P.H. at the Harvard T.H. Chan School of Public Health and complete a research fellowship at the Harvard Humanitarian Initiative. After training as a Surgical Critical Care fellow at Stanford University Medical Center, she joined the faculty as an Assistant Professor of Surgery in early 2018. She was promoted to Associate Professor in the University Medical Line in 2023. Her institutional leadership roles include serving as the Unit Based Medical Director of the Surgical Intensive Care Unit, the Associate Vice Chair of Research for the Stanford Department of Surgery, the SHC Surgical AI Lead for Early Clinical Deterioration, and the Associate Program Director for the Surgical Critical Care fellowship.
Dr. Knowlton is board certified by the American Board of Surgery and the Royal College of Physicians and Surgeons of Canada. Dr. Knowlton’s areas of clinical interest include developing safe surgical solutions for anatomic visualization in the operating room, artificial intelligence prediction tools for detection early clinical deterioration of surgery patients, optimizing the management of critically ill patients and reducing venous thromboembolism events.
Her research focuses on improving access to high-quality and high-value surgical care, merging expertise in health economics, and artificial intelligence to implement surgical innovations and health policy interventions. She leads novel work with the Department of Health Care Services focused on improving healthcare access and utilization through emergency Medicaid programs.
Dr. Knowlton’s research lab (https://med.stanford.edu/knowlton-lab.html) is funded by the Advanced Research Projects Agency for Health (ARPA-H), the National Institute of Health (NIMHD) through R21 and R01 grants, and the California Violence Prevention Center. She has also held funding through PCORI, the Department of Defense, the American College of Surgeons (the 17th C. James Carrico Faculty Research Fellowship), and the American Association for the Surgery of Trauma (AAST).
https://surgery.stanford.edu/news2/Knowlton-ARPA-H.html
She is active in national and international professional surgical societies, and recently served as the inaugural Chair of the Associate Member Council of the AAST. Dr. Knowlton has been recognized by the Association of Women Surgeons as both a ‘Shining Star’ and ‘Breaking the Glass Ceiling’ Leadership Scholar. She is also an American College of Surgeons Health Policy Scholar. Most recently, Dr. Knowlton was also selected as the 2023-24 U.S. ambassador for the James IV Surgical Association Traveling Fellowship program, where she will travel internationally to foster clinical and research collaborations. -
Susan Knox
Associate Professor of Radiation Oncology, Emerita
Current Research and Scholarly InterestsOur interests include 1) study of the effect of radiation on regulatory cell subpopulations and co-stimulatory molecules, 2) use of radiation as an immune modulator for optimization of transplant regimens, 3) the role of radiation in tumor vaccine strategies, 4) study of new radiosensitizers and radioprotectors, and 5) discovery of new targeted therapies for the treatment of solid tumors.
-
Eric I. Knudsen
Edward C. and Amy H. Sewall Professor in the School of Medicine, Emeritus
Current Research and Scholarly InterestsCellular mechanisms of spatial attention and learning, studied in the central nervous system in birds, using behavioral, systems, cellular and molecular techniques.
-
Justin M Ko, MD, MBA
Clinical Professor, Dermatology
BioDr. Ko joined Stanford Medicine in 2012 and serves as Director and Chief of Medical Dermatology for Stanford Health Care (SHC) while also spearheading the dermatology department's efforts around network development, digital health, quality/safety/performance improvement, and value-based care. He is active in a number of leadership roles within the organization including as an Associate Chief Quality Officer and physician dyadic partner to the Chief Experience Officer, as well as co-chair of the Clinic Advisory Council, a forum of medical and executive leaders of Stanford Health Care’s Ambulatory clinics.
His passion for melanoma, early cancer detection, and improving care delivery drives his efforts and research around leveraging advances in machine learning and artificial intelligence to increase the breadth of populations that can be reached. He developed and runs a digital care delivery program at SHC, providing virtual visits for patients and remote consultations for referring clinicians. He conducts research on and engages in collaborations around interventions that layer advances in machine learning on digital health capabilities to enhance access, quality and value of dermatologic care and is a founder and leader of the Stanford Translational AI in Dermatology (TRAIND) group. He chairs the American Academy of Dermatology's Committee on Augmented Intelligence.
Dr. Ko has also been driven to find new treatments for alopecia areata, an immune-mediated condition that can progress to total hair loss through various clinical trials and translational research efforts. He sits on the clinical research advisory board of the National Alopecia Areata Foundation and is a founder and co-director of the Skin Innovation and Interventional Research Group (SIIRG) which conducts clinical and translational research on skin disease.
He graduated magna cum laude from Harvard University and worked in investment banking; mergers and acquisitions at JP Morgan before going on to earn a combined medical and business degree at Tufts University. During medical school, he was a member of the Alpha Omega Alpha honor society. Dr. Ko then performed his residency at the Harvard Dermatology Residency Training Program where he served as chief resident. -
Brian Kobilka
Hélène Irwin Fagan Chair of Cardiology
Current Research and Scholarly InterestsStructure, function and physiology of adrenergic receptors.
-
Bruce Koch, Ph.D.
Director of High-Throughput Screening
Current Role at StanfordDirector, ChEM-H/CSB High Throughput Screening Group
Staff Lead, IMA HTS Module
Adviser to the SPARK Program -
Maximilian Koch
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsMy current research focuses on developing novel cellular immunotherapies for pediatric cancers. This includes identifying suitable MHC-restricted and native antigens that are expressed by malignant cells but ideally absent from healthy tissues. On the receptor side, both CARs and TCRs are being characterized for their specificity, affinity, and functionality. Ultimately, non-viral gene delivery methods will be explored and optimized to enable affordable, precise, and consistent cell products.
-
Justin Kochanski
Affiliate, Department Funds
Fellow in Pediatrics - CardiologyBioI'm passionate about delivering high quality, equitable care to patients with congenital heart disease.
-
Bob Kocher
Adjunct Professor, Health Policy
BioBob Kocher, MD is a Partner at Venrock and focuses on healthcare IT and services investments. He currently serves on the Boards of Devoted Health, Virta Health, Aledade, Lyra Health, Sitka, Need, Accompany Health, and Premera Blue Cross. He is a Board Observer at SmithRx, Stride, Suki, and The Public Health Company and previously Included Health (Grand Rounds + Doctor on Demand) and Castlight.
He is an Adjunct Professor at Stanford University School of Medicine and a Non-Resident Senior Fellow and Advisory Board Member at the Leonard D. Schaeffer Center for Health Policy and Economics at USC. He also serves on the Advisory Board of the National Institute of Healthcare Management (NIHCM).
Previously, Bob served in the Obama Administration as Special Assistant to the President for Healthcare and Economic Policy on the National Economic Council, as a Partner at McKinsey & Company, and is an internal medicine doctor. -
Kiran Kocherlakota
Director, Proposal Development Office, SoM Proposal Development Office
Current Role at StanfordDr. Kiran Kocherlakota is dedicated to empowering research faculty members to effectively compete for coveted funding opportunities
-
Gabriele Kockelkoren
Postdoctoral Scholar, Genetics
BioGabriele has a strong background in both physics and molecular biology and, accordingly, he strives in interdisciplinary environments. After completing a cum laude BSc. and MSc. in Nanobiology at the Technical University of Delft in The Netherlands, Gabriele pursued a PhD at the University of Copenhagen under the supervision of Prof. Dimitrios Stamou. In his PhD, Gabriele studied the nanoscale spatial organization of G protein-coupled receptors (GPCRs) at the plasma membrane of living cells. Importantly, his work reveals heterogeneous spatial patterns of receptor density and activation, that are modulated in a drug-dependent manner. These findings identify GPCR spatial organization as an integral element of their activity and signaling. Currently, Gabriele is a Postdoctoral Fellow in the lab of Prof. Alice Ting developing programmable receptors for molecular sensing and controlling cellular behaviour.
